Sign in
8-K

Current Report

Taysha Gene Therapies, Inc. Filed Acc 0001193125-20-291719

Acquisition or sale completed

  • Item 2.01 Completion of acquisition or disposition of assets

From the SEC's structured data for this filing

Loading d71631d8k.htm…